PlainPharmaWatch

CMS Open Payments · Program Year 2024

Aurobindo Pharma USA, Inc.

Aurobindo Pharma USA, Inc. reported $120,074.96 in payments to 137 physicians and teaching hospitals across 137 transactions.

See the rankings → How this is sourced
$120.1K
Total payments
137
Transactions
137
Recipients
#1135
of 1,925 companies

Aurobindo Pharma USA, Inc. reported $120,074.96 in payments to 137 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1135 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $876.46 per recipient across 3 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Aurobindo Pharma USA, Inc. pairs below-median payment volume with a moderately concentrated payment pattern.

#1135
of 1,925 companies
0.0%
of all US industry payments
0.3%
paid to its single top recipient
3
payment categories

How Aurobindo Pharma USA, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Aurobindo Pharma USA, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$120,075 41st percentile higher than 41% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). This entry sits in this band. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Aurobindo Pharma USA, Inc.

Rank #1135 of 1,925 companies in CMS Open Payments for 2024 belongs to Aurobindo Pharma USA, Inc., which reported $120,074.96 across 137 transactions to 137 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $876.46 per transaction and $876.46 per recipient.

Of the 3 general-payment categories charted below, "Consulting Fee" is the largest at $117.7K across 8 transactions, 98.1% of the company's reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

"Consulting Fee" leads Aurobindo Pharma USA, Inc.'s 3-category general-payment breakdown at $117.7K, 98.1% of the reported total.

How Aurobindo Pharma USA, Inc. divides its payments

General-payment categories, ordered by reported total

1. Consulting Fee$117.7K2. Travel and Lodging$1.7K3. Food and Beverage$657.43
Payment Type Amount Transactions
Consulting Fee $117.7K 8
Travel and Lodging $1.7K 40
Food and Beverage $657.43 89

Recipient Concentration in General Payments

The five largest recipient relationships account for $109,746.85 (91.4%) of $120,074.96 in this company's General Payments records across 8 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Aurobindo Pharma USA, Inc.

The five named recipients with the highest reported General Payments from this company

Robert Cotes$41.8KJohn Kane$40.6KDavid Sykes$19.4KKevin ZACHAROFF$4.3KCarol Tamminga$3.7K
  1. 1

    Robert Cotes

    $41,817.39 across 37 reported transactions

  2. 2

    John Kane

    $40,578.83 across 40 reported transactions

  3. 3

    David Sykes

    $19,377.54 across 26 reported transactions

  4. 4

    Kevin ZACHAROFF

    $4,262.14 across 12 reported transactions

  5. 5

    Carol Tamminga

    $3,710.95 across 6 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $876.46. Average per recipient: $876.46.

Total Amount

$120,074.96

Avg per Transaction

$876.46

Avg per Recipient

$876.46

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Aurobindo Pharma USA, Inc. Share

0.0%

#1135 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Aurobindo Pharma USA, Inc.

Novartis Gene Therapies, Inc. (fka Avexis, Inc.)

$120.0K 15 recipients

NuMED for Children, LLC

$120.0K 4 recipients

CorMedix Inc.

$120.2K 1,060 recipients

Shalby Advanced Technologies, Inc.

$120.5K 150 recipients

Ikon Spine LLC

$120.5K 15 recipients

Neptune Medical Inc.

$119.4K 49 recipients

Frequently Asked Questions

How much did Aurobindo Pharma USA, Inc. pay to physicians and hospitals in 2024? ▾
Aurobindo Pharma USA, Inc. made $120,074.96 in payments to physicians and hospitals in Program Year 2024, across 137 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Aurobindo Pharma USA, Inc.? ▾
Averaging $876.46 per recipient, Aurobindo Pharma USA, Inc.'s 2024 payments reached 137 physicians and teaching hospitals.
What types of payments did Aurobindo Pharma USA, Inc. make? ▾
3 categories of general payment make up Aurobindo Pharma USA, Inc.'s reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Consulting Fee" at $117.7K, representing 98.1% of the company's reported total.
How does Aurobindo Pharma USA, Inc. rank among pharmaceutical companies? ▾
Aurobindo Pharma USA, Inc. ranks #1135 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from Aurobindo Pharma USA, Inc.? ▾
The average transaction from Aurobindo Pharma USA, Inc. was $876.46 in 2024. The company made 137 total transactions to 137 recipients.
Where does the payment data for Aurobindo Pharma USA, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Aurobindo Pharma USA, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.